Skip to content

Retrospective clinical study on MRI cerebrospinal fluid film-assisted diagnosis of meningeal metastasis of lung cancer

Retrospective clinical study on MRI cerebrospinal fluid film-assisted diagnosis of meningeal metastasis of lung cancer

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500107113
Enrollment
Unknown
Registered
2025-08-04
Start date
2024-08-01
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung cancer

Interventions

Sponsors

The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Only patients who meet all of the following eligibility criteria can be enrolled in this trial: 1. Patients aged >=18 years, male or female; 2. Lung cancer confirmed by histological or cytological pathology; 3. Patients diagnosed with brain metastasis or meningeal metastasis; 4. Patients underwent magnetic resonance cerebrospinal fluid film imaging assessment.

Exclusion criteria

Exclusion criteria: Patients with any of the following will not be included in this study: 1. Currently combined with other tumors except NSCLC; 2. Suffering from other malignant tumors or having a history of other malignant tumors in the past 5 years, except for basal cell carcinoma of the skin, cervical carcinoma in situ and breast ductal carcinoma in situ that have been effectively controlled;

Design outcomes

Primary

MeasureTime frame
The accuracy of MRI cerebrospinal fluid film in predicting lung cancer with early meningeal metastasis;

Countries

China

Contacts

Public ContactQiming Wang

The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital

qimingwang1006@126.com+86 187 0383 7615

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026